Searchable abstracts of presentations at key conferences in endocrinology

ea0032p126 | Calcium and Vitamin D metabolism | ECE2013

Vitamin D and sarcopenia in HIV-infected patients

de Villar Noemi Gonzelez Perez , Perez Vicente Estrada , de Rivera Jose M Pena Sanchez , Gaviria Antonio Zapatero , Vicente Rosa Villar , Molina Gloria Canovas , Minchot Emilia Cancer , Robles Azucena Rodriguez , Larrad M Teresa Martinez , Rios Manuel Serrano

Introduction: Sarcopenia, an age-associated loss of skeletal muscle mass and function, has been related to higher mortality in general population as well as in HIV-infected patients. In elderly, sarcopenia is a marker of frailty. The aim of our study was to describe the prevalence of sarcopenia and related factors in HIV-infected population.Methods: Skeletal muscle mass (SMM), total fat mass and body fat distribution were measured by DXA scan. Muscle mas...

ea0056p133 | Endocrine tumours and neoplasia | ECE2018

Presence and functional role of KiSS/KiSS-R system in pancreatic neuroendocrine tumors (panNETs) and its relationship with clinical features and tumor behavior

Alors-Perez Emilia , Pedraza-Arevalo Sergio , Herrera-Martinez Aura , Diaz-Perez Angel J , Caro Teresa , Serrano-Blanch Raquel , Sanchez-Sanchez Rafael , Galvez-Moreno Maria Angeles , Castano-Fuentes Justo P , Luque Raul M , Martinez-Fuentes Antonio J

Pancreatic neuroendocrine tumors (panNETs) are the second most common neoplasm of the pancreas. panNETs arise from cells of the pancreatic islets and comprise a diverse and heterogeneous group of neoplasms. This hampers their systematic study, and the identification of common molecular signatures that might facilitate a better diagnosis of the disease, and the development of efficient therapeutic approaches. Indeed, there are no clinical, biochemical, anatomopathological, immu...

ea0073oc13.1 | Oral Communications 13: Pituitary and Neuroendocrinology | ECE2021

TP53 mutations in functional corticotroph tumours: prevalence and clinical relevance

Perez-Rivas Luis Gustavo , Simon Julia , Albani Adriana , Rotermund Roman , Hermus Perez-Rivas , Guillaume Assié , Gadelha Monica , Deutschbein Timo , Flitsch Jörg , Honegger Jürgen , Rachinger Walter , Stalla Günter , Reincke Martin , Theodoropoulou Marily

IntroductionTP53 mutations have been rarely reported in pituitary tumours. Recently two exploratory exome sequencing studies have identified somatic TP53 mutations in a small number of functional corticotroph tumours (6/18 and 4/10) with USP8 wild type (wt) status, suggesting that they may be more frequent than previously thought. Nevertheless, the clinical impact of those mutations is still unknown.AimTo det...

ea0099ep1268 | Late Breaking | ECE2024

Using a SGLT2 inhibitor does not modify the efficacy and tolerability of extended-release metformin in patients with type 2 diabetes

Santana-Ojeda Borja , Hernandez-Lazaro Alba , Jose de Leon-Durango Ricardo , Molinero-Marcos Inmaculada , Kuzior Agnieszka , Arnas-Leon Claudia , Maria Perez-Rivero Jennifer , Martin-Perez Marta , Gonzalez-Diaz Paula , Javier Martinez Martin Francisco

Introduction and Objectives: The tolerance of extended-release metformin (XRM) is superior to that of conventional metformin. XRM is recently available in Spain as a fixed combination with sitagliptin, but not in monotherapy. There are no data yet on how additional antidiabetic treatment can modify the effects of the XRM/sitagliptin combination. After assessing the efficacy and tolerability of XRM/sitagliptin in patients with T2DM labelled as metformin-intolerant and treated w...

ea0099ep1312 | Late Breaking | ECE2024

Improvement of blood pressure in patients with type 2 diabetes, labelled as metformin-intolerant when rechallenged with extended-release metformin

Kuzior Agnieszka , Maria Perez-Rivero Jennifer , Arnas-Leon Claudia , Hernandez-Lazaro Alba , Jose de Leon-Durango Ricardo , Santana-Ojeda Borja , Molinero Marcos Inmaculada , Acosta-Calero Carmen , del Pino Perez-Garcia Maria , Javier Martinez Martin Francisco

Introduction and Objective: Extended-release metformin has much better gastrointestinal tolerability than conventional (immediate release)metformin and according to the UK NICE guidelines should be offered to patients who have gastrointestinal tolerance issues with conventional metformin. We rechallenged patients with T2DM labelled as metformin-intolerant and treated with a DPP4i with a single-pill combination (SPC) of extended release metformin and sitagliptin (1000/50 mg) in...

ea0099ep1323 | Late Breaking | ECE2024

Quality of life improvement associated with the rechallenge with extended-release metformin in patients with type 2 diabetes labelled as metformin-intolerant

Molinero-Marcos Inmaculada , Hernandez-Lazaro Alba , Jose de Leon-Durango Ricardo , Rios-Gomez Carlos , Santana Ojeda Borja , Kuzior Agnieszka , Arnas-Leon Claudia , Maria Perez-Rivero Jennifer , del Pino Perez-Garcia Maria , Javier Martinez Martin Francisco

Introduction and Objectives: The tolerability of extended-release metformin (XRM) is clearly superior to that of conventional metformin, with the potential to improve patient compliance, effectiveness and outcomes. Since 2005 the NICE guidelines for type 2 diabetes mellitus (T2DM) recommend its use in patients with metformin-caused gastrointestinal disturbances. XRM is recently available in Spain as a fixed combination with sitagliptin, but not in monotherapy. We assessed the ...

ea0081p92 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Transforming growth factor beta 1: a new factor reducing hepatic sex hormone binding globulin production during liver fibrosis development

Brianso Llort Laura , Fuertes Rioja Lidia , Ramos Perez Lorena , Salcedo Allende Maria Teresa , Hernandez Cristina , Canonge Rafael Simo , Martinez David

Low plasma sex hormone-binding globulin (SHBG) levels are present in fatty liver disease, which represent a spectrum of diseases ranging from hepatocellular steatosis through steatohepatitis to fibrosis and irreversible cirrhosis. We have previously determined that fat accumulation reduces SHBG production in different non-alcoholic fatty liver disease (NAFLD) mouse models and that SHBG plays an active role in the development of this disease. In the present work, we are interes...

ea0081ep16 | Adrenal and Cardiovascular Endocrinology | ECE2022

Optimization of familial hypercholesterolemia diagnosis through LDL cholesterol correction formula for lipoprotein(a) levels

Borque Rosana Urdaniz , Gimeno Sergio Roman , Galende Elena Perez , Fernandez Gema Gonzalez , Martin Borja Sanz , Orna Jose Antonio Gimeno

Introduction: For the clinical diagnosis of heterozygous familial hypercholesterolemia (HeFH) validated algorithms are used, with the Dutch Lipid Clinic Network (DLCN) Criteria being the most recommended in our environment. One of the items that scores for the system proposed by the DLCN is the value of LDL cholesterol. However, LDLc levels can be distorted by lipoprotein a (Lpa(a)) levels.Objective: To analyze the change in the validity of the DLCN crit...

ea0081ep113 | Adrenal and Cardiovascular Endocrinology | ECE2022

Adrenal venous sampling in patients with hyperaldosteronism

Rebollo-Roman Angel , Serrano Laguna Ma del Carmen , Perez-Montilla Maria-Eugenia , Moreno-Moreno Paloma , Moreno Maria Angeles Galvez

Objective: Adrenal venous sampling (AVP) is a reliable procedure to differentiate if in patients with primary aldosteronism (PA) aldosterone production is unilateral or bilateral and guide the treatment of these patients. Our objective was to describe their characteristics and the outcomes of the AVPs.Methods and patients: Observational longitudinal clinical study between July 2020 and September 2021 in patients who underwent AVP in our Hospital.<p c...

ea0081ep401 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Efficacy of a groupal lifestyle intervention programme for weight loss in obesity

Cayon-Blanco Manuel , Cepero Dolores , Lopez-Perez M Jose , Garcia-Garcia-Doncel Lourdes , Baena-Nieto Maria Gloria

Introduction: Obesity is one of the most important problems worldwide in recent times. Groupal lifestyle intervention programmes are efficacious in the management of obesity. While exercise and healthy dietary habits have consistently been shown to improve various metabolic markers, adherence to these behaviors is low and methods that increase adherence to health behaviors are needed.Objective: The primary objective of this study is to evaluate the effec...